Excelsior Biopharma Inc
TPEX:6496
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Excelsior Biopharma Inc
TPEX:6496
|
TW |
|
M
|
Medigen Biotechnology Corp
TPEX:3176
|
TW |
|
H
|
Huikwang Corp
TPEX:6508
|
TW |
|
C
|
Cewe Stiftung & Co KGaA
XHAN:CWC
|
DE |
|
B
|
Biosenic SA
LSE:0R55
|
BE |
|
E
|
Econocom Group SE
F:1E91
|
BE |
|
B
|
Bank of Greece
DUS:BGC
|
GR |
|
R
|
Raba Jarmuipari Holding Nyrt
XMUN:RMV1
|
HU |
|
Bank of Greece
F:BGC
|
GR |
|
C
|
Cewe Stiftung & Co KGaA
XMUN:CWC
|
DE |
|
Bleichroeder Acquisition Corp II
NASDAQ:PSQL
|
US |
|
G
|
Garuda Indonesia (Persero) Tbk PT
F:YGD
|
ID |
Dividends
Dividend Yield
Excelsior Biopharma Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Excelsior Biopharma Inc
Payout Ratio
Excelsior Biopharma Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Excelsior Biopharma Inc is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Excelsior Biopharma Inc
| Average Annual Return | -3.57% |
| Standard Deviation of Annual Returns | 8.99% |
| Max Drawdown | -37% |
| Market Capitalization | 1.1B TWD |
| Shares Outstanding | 47 290 000 |
| Percentage of Shares Shorted |
N/A
|
